Advertisement

Author: Devin Weiss

Krispy Tops, Outlook Bright – Analyst Blog

Krispy Kreme Doughnuts Inc. (KKD) posted first quarter 2013 adjusted earnings of 12 cents per share. The results surpassed the Zacks Consensus Estimate by 7 cents and the year-ago earnings by 6 cents. On a reported basis, Krispy...

Read More

Open Text – Value

Information Management Software provider Open Text Corp. (OTEX) is an attractive pick for value investors. This Zacks #1 Rank (Strong Buy) is expected to benefit from the strong growth opportunities in its core end-market, as...

Read More

Home Depot – Growth & Income

Home Depot Inc. (HD) has an impressive record of beating quarterly earnings expectations, which it continued in its fiscal second quarter 2012 by surpassing the Zacks Consensus Estimate by 4.1%. The home improvement retailer has...

Read More

Devry (DV) – Bear of the Day

Devry (DV) was recently downgraded from Neutral to Underperform. The downgrade comes as the company reported dismal fourth quarter results. Both top and bottom lines declined on a sequential as well as year over year basis....

Read More

GATX Corp. – Aggressive Growth

GATX Corp. (GMT) has delivered four consecutive quarters of positive earnings surprises, outpacing the Zacks Consensus Estimate by an average of 23.6%. Higher lease rates, better asset utilization, improvement in lease terms and...

Read More

PDF Solutions – Momentum

PDF Solutions, Inc. (PDFS) is a technology and service provider for integrated chip (IC) manufacturers, and its shares have been trending higher since reporting its second quarter results on August 8. Currently, this Zacks #2...

Read More

Medicines Company (MDCO) – Bull of the Day

Medicines Company (MDCO) was upgraded from Neutral to Outperform following a solid earnings report and positive earnings surprise. The beat was positive but we are also excited by the progress in the pipeline for the second half...

Read More

DARA Biosciences Inks Deal – Analyst Blog

DARA Biosciences, Inc. (DARA) recently entered into an exclusive distribution agreement with Seyer Pharmatec Inc. to sell and distribute the breast cancer product Soltamox in the Commonwealth of Puerto Rico. The company intends...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.